Allarity Therapeutics, Inc. (ALLR)
1.31
+0.05
(+3.80%)
USD |
NASDAQ |
Sep 10, 09:31
Allarity Therapeutics Shareholders Equity (Quarterly) : 3.536M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.536M |
| March 31, 2026 | 6.92M |
| December 31, 2025 | 9.828M |
| September 30, 2025 | 12.01M |
| June 30, 2025 | 12.17M |
| March 31, 2025 | 18.67M |
| December 31, 2024 | 11.81M |
| September 30, 2024 | 12.96M |
| June 30, 2024 | 19.84M |
| March 31, 2024 | -6.471M |
| December 31, 2023 | -2.751M |
| Date | Value |
|---|---|
| September 30, 2023 | -3.379M |
| June 30, 2023 | -0.723M |
| March 31, 2023 | -0.339M |
| December 31, 2022 | 1.89M |
| September 30, 2022 | 3.503M |
| June 30, 2022 | 10.08M |
| March 31, 2022 | 16.87M |
| December 31, 2021 | 18.78M |
| September 30, 2021 | 29.66M |
| June 30, 2021 | 28.82M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.12M |
| Total Liabilities (Quarterly) | 28.58M |
| Debt to Equity Ratio | 6.303 |
| Current Ratio | 1.110 |
| Net Debt Paydown Yield | -20.39% |